APA (7th ed.) Citation

Y, S., A, M., M, D., M, M., JW, H., A, D., . . . JML, E. (2025). Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors. EMBO reports, 26(2), 521. https://doi.org/10.1038/s44319-024-00333-0

Chicago Style (17th ed.) Citation

Y, Shi, et al. "Acquired Resistance to PD-L1 Inhibition Enhances a Type I IFN-regulated Secretory Program in Tumors." EMBO Reports 26, no. 2 (2025): 521. https://doi.org/10.1038/s44319-024-00333-0.

MLA (9th ed.) Citation

Y, Shi, et al. "Acquired Resistance to PD-L1 Inhibition Enhances a Type I IFN-regulated Secretory Program in Tumors." EMBO Reports, vol. 26, no. 2, 2025, p. 521, https://doi.org/10.1038/s44319-024-00333-0.